Protein pump inhibitors go over the counter.
Neafsey
Patricia
P
D000282:Administration, Intravaginal; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects; D001189:Aryl Hydrocarbon Hydroxylases / Q000172:deficiency; D065731:Cytochrome P-450 CYP2C19; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D006899:Mixed Function Oxygenases / Q000172:deficiency; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D009853:Omeprazole / Q000627:therapeutic use*; D012651:Self Medication / Q000009:adverse effects; D013276:Stomach Ulcer / Q000139:chemically induced
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000935:Antifungal Agents; D004791:Enzyme Inhibitors; D004366:Nonprescription Drugs; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D009853:Omeprazole